| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8760 |
| Human Intestinal Absorption | HIA+ | 0.9890 |
| Caco-2 Permeability | Caco2+ | 0.8518 |
| P-glycoprotein Substrate | Non-substrate | 0.6659 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.5791 |
| Non-inhibitor | 0.7525 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8742 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8711 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8126 |
| CYP450 2D6 Substrate | Non-substrate | 0.8400 |
| CYP450 3A4 Substrate | Non-substrate | 0.5851 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5728 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8912 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9379 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.5839 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.7406 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5128 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9535 |
| Non-inhibitor | 0.9606 |
| AMES Toxicity | Non AMES toxic | 0.7381 |
| Carcinogens | Non-carcinogens | 0.8445 |
| Fish Toxicity | High FHMT | 0.9897 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9882 |
| Honey Bee Toxicity | High HBT | 0.8377 |
| Biodegradation | Ready biodegradable | 0.5000 |
| Acute Oral Toxicity | III | 0.8552 |
| Carcinogenicity (Three-class) | Non-required | 0.6079 |